Latka logo
ChoiceMap logo

ChoiceMap

Seattle, Washington, United States

2021 Revenue

$242.4K

Team

3

Founded

2014

ChoiceMap Revenue (2021)

ChoiceMap generated $242.4K in revenue in 2021.

Developer of medical software designed to help doctors make personalized patient treatment decisions. The company's medical software helps people choose birth control methods, child planning, baby names, career paths and vacation destinations and it can personalize treatment options for each patient and the patient adjusts priorities, enabling doctors and patients make complex treatment decisions together through a cloud-based platform in the United States.

Last updated

ChoiceMap Revenue

In 2021, ChoiceMap's revenue reached $242.4K.

ChoiceMap Revenue GrowthReported revenue / ARR over time$0$60K$120K$180K$240K$300K20142015201620172018201920202021$0$242.4KSource: GetLatka.com
YearMilestoneSource
2021ChoiceMap Hit $242.4k revenue in April 2021Not recorded
2014Launched with $0 revenue

Founder / CEO

ChoiceMap Employees & Team Size

ChoiceMap employs approximately 3 people as of 2026.

ChoiceMap Team GrowthReported headcount over time012234201420152016201720182019202020210033Source: GetLatka.com
YearMilestoneSource
2021Reached 3 employees (April 2021)Not recorded

Frequently Asked Questions about ChoiceMap

Is ChoiceMap still operating?

No. ChoiceMap has shut down.

What is ChoiceMap's revenue?

As of 2021, ChoiceMap generated $242.4K in revenue.

Who founded ChoiceMap?

ChoiceMap was founded by Jonathan Jackson.

When was ChoiceMap founded?

ChoiceMap was founded in 2014.

How many employees does ChoiceMap have?

As of 2021, ChoiceMap had 3 employees.

Where is ChoiceMap headquartered?

ChoiceMap is headquartered in Seattle, Washington, United States.

Compare ChoiceMap to the industry

ChoiceMap operates across multiple industries. Browse revenue, funding, and growth data for ChoiceMap in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile